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Strategies that confine antibacterial and/or antifouling property to the surface of the implant, by modifying
the surface chemistry and morphology or by encapsulating the material in an antibiotic-loaded coating, are
most promising as they do not alter bulk integrity of the material. Among them, plasma-assisted
modification and catechol chemistry stand out for their ability to modify a wide range of substrates. By
controlling processing parameters, plasma environment can be used for surface nano structuring,
chemical activation, and deposition of biologically active and passive coatings. Catechol chemistry can
be used for material-independent, highly-controlled surface immobilisation of active molecules and
fabrication of biodegradable drug-loaded hydrogel coatings. In this article, we comprehensively review
the role plasma-assisted processing and catechol chemistry can play in combating bacterial colonisation
on medically relevant coatings, and how these strategies can be coupled with the use of natural
antimicrobial agents to produce synthetic antibiotic-free antibacterial surfaces.al Engineering, Queensland University of
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hemistry 20151. Introduction
In the last twenty years, signicant progress has been made in
the development of biomaterials and implantable devices,
which are characterised by superior biocompatibility, desired
integration with peri-implant tissues, controlled fouling with
host cell and biomolecules, and which cause minimal acute or
chronic inammation. Numerous modication techniques
have been developed to ensure satisfactory clinical performance
of these devices by improving their biocompatibility withAssociate Professor Mohan Jacob
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Research Education for the
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and Engineering, James Cook
University. University of Delhi
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the development of polymer thin lms and graphene from
sustainable sources using plasma enhanced chemical vapor
deposition, environmentally friendly biomaterials and electronic
and biomedical devices.
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View Article Onlinecells/tissues, by tailoring chemical composition andmechanical
properties for specic application. To illustrate, metals such as
titanium (Ti) are frequently modied by grain renement to
improve mechanical properties and enhance osteoblast
attachment; abrasive-blasted to modify topography and thus
improve osseointegration; polished mechanically and
chemically to achieve smooth surface morphology to reduce
integration with tissues and ease the removal of the devices
(short-term implants); passivated/oxidised to improve
corrosion resistance and enhance bioinertness; and coated
with biomolecules, e.g. proteins and DNA fragments, and
other biologically active species for guided cell attachment
and integration with host tissues, to name but a few.
At the same time, the susceptibility of the implant surface to
bacterial colonisation and biolm formation remains a major
problem that is most commonly dealt with by means of
prophylaxis with systemic antibiotics. Although administration
of broad-spectrum systemic antibiotics is effective in preventing
biomaterial-associated infection arising from pathogens intro-
duced into the peri-implant space in the course of surgery or
post-operative care, the practice is far less effective in dealing
with late haematogenous infections. In the case of the latter,
bacteria from an inammation site elsewhere in the body can
enter the blood stream and thus be transferred to the implant
surface. In the absence of antibacterial agent, there is little to
stop the pathogen from attaching to the surface and initiating a
biolm formation. The colonisation occurs quickly and is rarely
detected clinically in time to prevent biolm formation. Once
formed, the biolm affords the pathogenic cells necessary
protection against ow detachment, opsonisation, and the
harmful effects of host antimicrobial molecules and systemicDr Wojciech Chrzanowski joined
the University of Sydney in 2010
and he has established the Bio-
interface group and Bio-nano-
characterisation laboratory
within the Faculty of Pharmacy.
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Tokyo University and Chubu University). Dr Chrzanowski pub-
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48740 | RSC Adv., 2015, 5, 48739–48759antibiotics.1 In biolm state, the expression of genes and
metabolic activity in bacterial cells may also differ from that of
their planktonic counterparts, which may lessen sensitivity of
sessile bacteria to certain antimicrobials designed to target the
pathogen's metabolism.2–4 Oentimes, even signicantly higher
doses of systemic antimicrobials are insufficient to clear the
biolm, and implant replacement is required.
Although sound hospital practices ensure the rate of
implant-associated infections remains relatively low, the ever
increasing volume and variety of biomaterials and medical
devices implanted globally results in a substantially large
number of infections. Furthermore, increasing human life
expectancy and emphasis on active lifestyle is associated with a
growing number of revision surgeries, and these are known to
have a signicantly higher infection rate. With the growing
issue of hospital acquired and multi-drug resistant microor-
ganisms,5 there is a strong need to engineer biomaterials that
retard microorganism colonisation in the rst place.2. Trends in surface modification
Microbial attachment can be effectively mitigated by intro-
ducing an antimicrobial agent throughout the bulk of the
material, e.g. silver can be blended into bulk polymeric mate-
rials, alloyed into metallic biomaterials, or introduced into
glass/ceramic materials.6–8 While the nature of the resultant
material ensures the long-lasting antimicrobial effect, the
addition of the antibacterial agent may negatively impact on the
fundamental properties, stability or processability of the
material. In comparison, surface modication can be applied to
existing biomaterials, with little impact on such bulk propertiesProfessor Kostya (Ken) Ostrikov
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Fellow, Chief Research Scientist
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This journal is © The Royal Society of Chemistry 2015
Fig. 1 (A) Antifouling strategies for biofilm management. (B)
Commonly used hydrophilic chemistries, e.g. poly(ethylene glycol),
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View Article Onlineas mechanical strength and stability under in vivo conditions,
and is oen more cost and time effective.9,10
When selecting appropriate surface modication approach,
there are many material- and application-based considerations
that need to be addressed. From processing point of view, the
choice of the appropriate method is based on its compatibility
with the type of biomaterial, i.e. polymeric, metallic, ceramic or
composite; its stability, i.e. temperature sensitivity, solubility,
mechanical robustness, etc.; its physical structure, e.g. porosity,
and dimension, e.g. bulk or thin lm; to name a few.
Financial cost, ease of integration, and scalability of poten-
tial modication techniques also need to be considered. For
instance, chemical vapour deposition of vertically aligned
carbon nanotube forests consumes more time, energy and
resources than template-based fabrication of polymer struc-
tures. The former is also more difficult to scale up or translate
into continuing processing. At the same time, nanoscale
materials, such as nanotubes or graphene sheets offer unique
and highly valuable properties, such as extreme mechanical
strength and durability, electrical and thermal conductivities,
and highly adjustable chemical reactivity. Indeed, although
relatively easy to fabricate, polymer structures are more fragile
and fail easily under load or wear conditions.
From application perspective, general considerations
include the intended use, e.g. whether the surface will be sub-
jected to load, wear, ow or harsh chemical environment, as
well as the length for which antimicrobial activity is required.
The proposed application also places restrictions on the type of
antimicrobial activity, for example antibiofouling surfaces may
be desirable for urinary tract catheters, but they will not be
appropriate for materials where tissue regeneration is required.
In general, a biomaterial with excellent bactericidal activity but
poor compatibility with host biomolecules, cells and tissues is
unlikely to nd broad clinical use.
Even a non-cytotoxic coating aimed at preventing bacterial
adhesion may change the density or porosity of the underlying
material, with signicant consequences for attachment, differ-
entiation and metabolic activity of target mammalian cells.
Changing surface topography of the biomaterial may also
change the availability of specic chemical functionalities at its
surface, or recongure their 3D conrmation. It is therefore
important to understand the interdependence of surface
chemistry and physics in order to adequately predict the
resultant biological performance with respect to bacteria and
mammalian cells.11
The type of antimicrobial agent, its ability to withstand
processing conditions, and maintain its antimicrobial potency
in the nal conformation under physiological conditions will
also affect the choice of modication methodology.poly(methyl oxazoline), polyacrylamide, and zwitterionic poly-
(carboxybetaine methacrylate) and poly(sulfobetaine methacrylate).
(C–G) Natural and artificial superhydrophobic surfaces. (C) The hier-
archical structure of Salvinia spp. hairs, composed of the multicellular
hair with small rodlet-like wax crystals on top.15 (D) Macroporous
graphene oxide film (CA ¼ 152).16 (E) Gecko-inspired setae made of
micropatterned carbon nanotube bundles (CA ¼ 155).17 (F) Per-
fluoropolyether polymer hairs (CA ¼ 171).18 (G) Epoxy/g-Al2O3
nanoparticle composite (CA ¼ 160).19 Reproduced with permission
from ref. 15–20.2.1 Physico-chemical modications
For a number of years, control over the attachment and biolm
formation of microorganisms was achieved using specic
surface chemistries. This is hardly surprising, as molecular
recognition is acknowledged as one of the key factors in deter-
mining not only cell–surface interactions, but also manyThis journal is © The Royal Society of Chemistry 2015biological functions within the cell itself. These chemistries can
be imparted onto the surface by a variety of means, including
plasma-assisted techniques, such as plasma (thermal) spraying,
plasma immersion ion implantation, and plasma deposition,
gas dynamic cold spraying, chemical and physical vapour
deposition, and sol–gel. Hydrotropic nanostructues, such as
carbon and halloysite nanotubes can also be used to control
fouling.12 The key challenge in using these methods is in
ensuring that the treatment process and/or the resultant surface
chemistry do not undermine the biocompatibility, performance
and degradation behaviour of the biomaterial in vitro and in vivo.
With the development of novel data acquisition, analysis and
visualisation tools, our understanding of cell–surface dynamics
have evolved to include the physical as well as the chemical
properties of biomaterials as key factors that can regulate bio-
logical responses of cells and tissues.13 As a result, several
modication strategies have been developed that rely on the
synergistic effect of chemistry, e.g. hydrophobic moieties, and
surface morphology, e.g. hierarchical arrangement of nano- and
micro-features, to prevent microbial attachment and biolm
formation (Fig. 1).14 Laser ablation, abrasive blasting, physical
vapour deposition, self-assembly, evaporation and ion assisted
deposition are among the frequently used physical modication
techniques.
Nanostructured surfaces with surface chemistry-
independent antimicrobial effect have also been reported.21
Fig. 2 shows the nanopattern on the surface of Clanger cicadaRSC Adv., 2015, 5, 48739–48759 | 48741
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View Article Online(Psaltoda claripennis) wings which allows the surfaces to kill
bacteria on contact based solely on its physical surface struc-
ture. Although unable to prevent microbial attachment,22 the
direct contact between the attached cells and highly ordered
arrays of surface nanopillars resulted in cell membrane
stretching and eventual rupturing, where the adsorption
behaviour of bacterial cells and their sensitivity to the material
surfaces depended both on the geometry of the pillars and the
mechanical properties of the cells, especially cell rigidity.21 In
spite of substantial advances in our understanding of how the
physical properties of materials determine cell–surface
dynamics at nano-, molecular- and atomic scales, this eld
requires considerable further development.
Surface physical properties can be used to enhance the
antimicrobial effect. For instance, physical disruption of cell
membranes have been demonstrated as an essential contrib-
utor to antimicrobial efficacy of copper surfaces, where the
damage to cell envelope facilitated further damage by copperFig. 2 The unique surface morphology of wing surface enables
Clanger cicada (A) to resist bacterial colonisation. (B) Proposed
mechanism of chemistry-independent contact killing of bacteria on
cicada wing surface. (C and D) SEM images of clinically relevant
pathogens on the surface of a cicada wing. Pseudomonas aeruginosa
(C) and Branhamella catarrhalis (D) cells are clearly penetrated by the
nanopillar structures on the wing surface, with cells sinking between
the nanopillars (C, inset). On the wing surfaces, bactericidal effect
observed for all tested Gram-negative microorganisms, regardless of
cell morphology. On glass (D, inset) under equivalent incubation
conditions, no killing effect was observed. Reproduced with permis-
sion from ref. 21, 22 and 25.
48742 | RSC Adv., 2015, 5, 48739–48759ions,23 and of copper containing nanoparticles, where particles
also acted as physical carriers of copper into the cells.24
2.2 Biocide-based strategies
Broadly, the antimicrobial agent can either be entrapped in the
coating to be released in some predened fashion upon inter-
action with its operational environment and/or stimuli, e.g.
drug eluting hydrogels and coatings, or immobilised on the
surface of the implant to prevent bacterial attachment and/or
kill the attached cells on contact, e.g. covalently attached poly-
mer brushes, conventional antibiotics and antimicrobial
peptides.
There is merit to both strategies. Themain advantage of non-
leaching systems is in the connement of the cytotoxic effect to
the surface of the implant, thus minimising the potentially
harmful interactions between the agent and host tissues, e.g.
damage to host cells in peri-implant milieu or accumulation of
the antimicrobial liver, spleen, and brain.26,27 Given that the
antimicrobial agent is not depleted over time, the effect is
sustained for longer. Furthermore, the issue of bacterial cells
being exposed to sub-inhibitory concentrations of the antibiotic
is avoided. This minimises the chance these bacteria will
develop resistance to the drug in use.28
With the efficacy of many antimicrobials relying on a
combination of chemical functionality and spatial conforma-
tion, covalent immobilisation is more conducive to attaining
specic molecular orientation of the agent on the surface. As
such, the availability of specic chemistries and structural
motifs characteristic of the antimicrobial in suspension can be
maintained.29 Nevertheless, prolonged exposure to the physio-
logical environment may result in the concealment of the
antimicrobial chemical and physical features of the surface, e.g.
through adsorption of host biomolecules or accumulation of
killed bacterial cells and their fragments.30 Furthermore, a
broader variety of antimicrobial agents can be entrapped in the
release- or leach-systems, and their concentration and release
rate controlled to ensure bacterial inhibition further away from
the implant surface into the peri-implant space. The challenge
that is common to drug-release and non-leaching antimicrobial
systems is the control over the quality of adhesion between the
active agent and the underlying biomaterial surface.
The example in Fig. 3 shows the use of traditional antibiotics
as biocidal agents. For antibiotic-sensitive strains of bacteria,
these coatings provide an effective means of combating infec-
tion. However, a growing emergence of bacteria with antibiotic
resistance, particular in hospital settings, resulted in a growing
interest in alternative therapeutic concepts and agents. Ideally,
these alternative agents should lead to the elimination of
bacteria, and have a mode of action that would be sufficiently
dissimilar to systemic antibiotics to avoid promoting cross-
resistance.
2.3 Aim and article organisation
The aim of this article is to review two types of highly-versatile
modication chemistries, namely (i) highly reactive plasma
chemistry and (ii) catechol chemistry that can be applied to aThis journal is © The Royal Society of Chemistry 2015
Fig. 3 Principles of bactericide contact and release coatings based on
conventional antibiotics (penicillin, ampicillin, and gentamicin). Anti-
biotics can be used individually or in combination. Active agents can be
physically adsorbed onto the surface or covalently conjugated to the
polymer chain (in this example, PEG).
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View Article Onlinewide range of substrate materials to produce a variety of anti-
fouling, biocide-releasing and contact kill surfaces. A particular
focus of this review is the potential use of plasma and catechol
chemistries as enabling technologies for surface modication
based on natural antimicrobial compounds.
Section 2 will provide a broad perspective on surface modi-
cation of biomaterials for controlling microbial attachment
and biolm formation, giving examples of desirable surface
properties and the methods that are used to attain these prop-
erties. Given the vast variety of materials, applications and
surface modication methodologies, the fully exhaustive
coverage of the relevant existing knowledge is outside the scope
of this review.
Section 3 will discuss two broad classes of natural antimi-
crobial compounds, specically secondary plant metabolites
and antimicrobial peptides, as a viable alternative to conven-
tional systemic antibiotics.
Section 4 will review catechol chemistries inspired by the
distinctive water-resistant, material-independent adhesive
abilities of many sessile aquatic organisms.31 This section will
discuss the relevance of this chemistry to both the assembly of
well-adhering releasing hydrogels and for the design of
substrate-independent adhesive coatings that can serve as a
base layer for further functionalization, such as covalent
binding of natural antimicrobial agents.
Section 5 will review general principles of plasma assisted
surface modication, as a technique that can be used for
surface patterning, deposition of contact killing and drug
eluting coatings and for surface functionalization that can be
subsequently used for drug immobilisation in non-release
systems. Section 5 will concentrate on select examples of
using plasma environment to process natural antimicrobial
agents into bioactive coatings.This journal is © The Royal Society of Chemistry 20153. Antimicrobials of natural origin
The use of systemic antibiotics has been challenged on many
levels, the key issue concerned with its contribution towards the
development of microbial resistance. And while these agents
remain among the most potent weapons in treating advanced
infections, there has been an increasing interest in the use of
alternative, nature-derived antimicrobials, whose physico-
chemical structure and mechanism of bioactivity are suffi-
ciently dissimilar to those of currently used synthetic antibiotics
to eliminate the possibility of bacterial cross-resistance. Devel-
opment of cross-resistance is an important problem, and
methicillin resistant Staphylococcus aureus is one of the best
known examples of microorganisms with multi-drug resistance
against most currently available antibiotics, including recent
cases of vancomycin-resistant S. aureus.
Other notable clinically signicant drug-resistant pathogens
include Acinetobacter baumannii, P. aeruginosa, E. coli and
Klebsiella pneumoniae resistant to b-lactamases, and Mycobac-
terium tuberculosis.32 Although some bacterial organisms are
intrinsically resistant to some antimicrobials, excessive use
and/or misadministration of antibiotics may select for patho-
gens that acquired resistance by either de novomutations or via
gene transfer, conjugation, transformation, and transduction.32
These newly acquired genes can complement and thus enhance
the intrinsic resistance of the microorganism.
Phenotypically, the changes in genotype can manifest in
many ways, including synthesis of enzymes capable of deacti-
vating antibacterial agent, physico-chemical changes to the site
targeted by the antimicrobial, activation of an alternative
metabolic pathway to circumvent the activity of the drug, and to
minimise the accessibility of internal drug targets via various
efflux mechanisms. Amongst numerous alternative antimicro-
bials, metal ions, nitric oxide, antimicrobial peptides, and
secondary metabolites derived from plant organisms provide a
diverse range of antimicrobial agents.3.1 Antimicrobial peptides
Antimicrobial peptides are produced by all complex organisms
as well as some microbes as part of innate immune response,
and display diverse and complex antimicrobial activities against
a broad range of Gram negative and Gram positive bacteria,
including those resistant to established antibiotic drug thera-
pies, mycobacteria, enveloped viruses, parasites and fungi.35,36
Also known as host defense peptides, these are low molecular
mass amphipathic molecules of 12–50 amino acids in length,
and are secreted by many different cell types, either constitu-
tively or in response to inammatory stimuli.37 These molecules
typically perform more than one function within the organism
(Fig. 4). For instance, peptides produced by neurons, e.g.
neurokinin-1, neuropeptide Y, orexins, function as both the
neurotransmitters in the brain and the peripheral nervous
system, and as immunomodulators, regulating immune func-
tion and neurogenic inammatory responses through vasodi-
latation, plasma extravasation, and recruitment of
immunocompetent cells.35,38–40 Orexin B has been reported toRSC Adv., 2015, 5, 48739–48759 | 48743
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View Article Onlineaffect the function of peritoneal macrophages via activation of
calcium-dependent potassium channels and to facilitate
enhancement of phagocytosis in mouse peritoneal
macrophages.38,41
In plants, thionins, defensins, lipid transfer proteins, hevein-
and knottin-like peptides, MBP1, IbAMP, and the recently
reported snakins are the most commonly encountered antimi-
crobial peptides.42 Structurally, these are small cationic peptides
with molecular masses of 2–10 kDa, with their structure stabi-
lized via the formation of 2–6 disulde bridges. The antibacterial
mechanism of thionins is through the binding of phospholipids
of the bacterial membrane which initiates a cascade of cyto-
plasmic events leading to cell death.43,44 High positive charge,
which renders them extremely soluble (>300 mg ml1), and the
phospholipid-binding specicity of thionin allows the agent to
bind areas of negatively charged phospholipids, eitherFig. 4 (A) Overview of the biological activities of host defense
peptides (HDPs) and innate defense regulator (IDR) peptides. Direct
cytotoxic activities are shown in green, direct and indirect immuno-
modulatory properties are in blue and pink, respectively. ROS, reactive
oxygen species; NO, nitric oxide.33 (B) Overview of the broad spectrum
of cellular interactions associated with antimicrobial peptides.
Peptides exert antimicrobial activity by disrupting bacterial
membranes, binding to specific target proteins within microbial cells
and activating the innate immune system.34 Reproduced with
permission from ref. 33 and 34.
48744 | RSC Adv., 2015, 5, 48739–48759phosphatidic acid or phosphatidyl serine, and their subsequent
withdrawal. The segregation of phospholipids destabilizes the
membrane, causing its solubilisation and lysis.
Defensins, typically 45–54 amino acids long cationic
peptides, display only modest antimicrobial activity, with sound
efficacy against diverse fungi.45,46 Specic defensins have also
been reported to inhibit protein synthesis, protease trypsin, or
a-amylase activity.45 Lipid transfer proteins range in size
between 7 and 10 kDa, and are typically of globular structure
with a large hydrophobic cavity. The cavity serves as a binding
site for mono- or diacylated lipids and other hydrophobic
molecules, with a larger cavity of LTP2 allowing it to bind a
planar sterol.
In terms of the use of antimicrobial peptides as antibacterial
surface modication, numerous strategies have been tested to
deliver these antimicrobials to the site of implantation. The
ionic self-complementary of peptides allows for their use as
building blocks for self-assembly of nanostructures. Each
amphipathic molecule is comprised of distinct hydrophilic and
hydrophobic regions. In aqueous environment, the hydro-
phobic region tries to minimise its exposure to water, resulting
in folding of the molecule. The hydrophilic domain is
composed of alternating positively charged (e.g. arginine,
lysine) and negatively charged (e.g. aspartate, glutamate) amino
acid residues, with various patterns of distribution of the
charged residues. These residues will engage in ionic interac-
tions with the oppositely charged residues of the complimen-
tary molecule, driving the self-assembly. Although non-covalent
in nature, the interactions are sufficiently strong to support
highly stable structures.
Hydrogels of b-hairpin peptides rich in arginine displayed
strong antibacterial activity against Gram-positive and Gram-
negative bacteria, including multi-drug resistant P. aerugi-
nosa.47 The fundamental and functional properties of the
hydrogel, including killing efficacy, host cytocompatibility, bulk
rheological properties and stimuli-responsiveness of this type of
hydrogel can be controlled via selection of the specic peptide
sequence at the monomer level.48–50 Pre-functionalisation of the
implant surfaces, e.g. via plasma-assisted treatment, has been
used for UV immobilisation of 3-poly-L-lysine-gra-meth-
acrylamide hydrogel thin lm.51 Coupled with excellent activity
against bacteria and fungi, the low thickness of the coating
makes it a good candidate for coating over medical devices and
implants.
A mode of delivery via loading of antimicrobial peptides into
a carrier platform has been trialled. Kazemzadeh-Narbat et al.
used micro-porous octacalcium phosphate lms to load broad
spectrum antimicrobial peptides for orthopaedic applications.52
Shukla et al. used thin layers of polyionic polymer lms to
physically entrap the antimicrobial agent, varying layer number
and composition for control over the amount of agent loaded
into the structure.53 It has been suggested that the antimicrobial
agent may not be able to diffuse through the layers of the
polymer at a sufficient rate to ensure the steady level of the
antimicrobial at the surface. In addition to the intrinsic prop-
erties of the layers, through which the peptide is to diffuse, itsThis journal is © The Royal Society of Chemistry 2015
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View Article Onlinerelease may also be limited by the bacterial cells accumulated at
the surface of the implant.54
Physical and chemical immobilisation of the peptide on the
surface of the implant can circumvent the issues with diffusion,
although accumulation of bacterial debris may still remain a
challenge.56 Although reported as an effective approach for
peptide surface immobilisation, non-specic physical adsorp-
tion may compromise the availability of physico-chemical
particulates of the peptide present in the soluble analogue,
potentially rendering the coating inactive.55 Even specic,
covalent attachment of the peptide is likely to affect the struc-
tural exposure and exibility characteristic of the peptide.29 For
instance, even though notably larger amounts of peptide per
unit area can be conjugated to a surface via polymer brush
compared to the direct graing of peptides, a signicant
portion of these peptides may not be available to interact with
biomembranes due to steric restrictions exerted by the polymer
brush structure.55 On the other hand, the surface-tethered
peptides may be more effective in combating microbial colo-
nisation due to higher concentration of appropriately struc-
tured peptides in one location (Fig. 5).
To minimise the detrimental effects of the binding, many
methods have been developed, employing a variety of chemical
coupling strategies, length of spacers, and peptide orientation
and concentration.57,58 Many of these strategies focus on mini-
mising nonspecic interactions between the peptide and the
substrate.59 Another important consideration in using peptideFig. 5 Proposed mechanism of action of free (A) and polymer brush-
immobilized host defense peptide (B). In (B), more peptides adopt a
structure before they interact with the membrane, and therefore there
may be more structured peptides localized in one area when they
bind/insert into the membrane. As a result, perturbation of the
membrane may be more efficient. Reproduced with permission from
ref. 55.
This journal is © The Royal Society of Chemistry 2015antimicrobials is their stability,60 as well as the stability of the
coating system as a whole under physiological conditions.613.2 Antimicrobial secondary plant metabolites
Plants produce a broad assortment of secondary metabolites,
including tannins, terpenoids, alkaloids, polyphenols and
avonoids, which have been found in vitro to have antimicrobial
properties against both Gram positive and Gram negative
bacteria. Furthermore, these phytochemicals have been shown
tomodulate or modify resistance mechanisms in bacteria.62 Yet,
since the discovery of penicillin in the 1950s, the medical world
has relied on antibiotics derived from bacterial and fungal
sources, with the use of plant derivatives as antimicrobials
being nearly non-existent.63 One of the possible reasons for this
is that the relatively higher minimum inhibitory concentrations
limited their utility as the sole agents, although certain
combination of phytochemicals with conventional antimicro-
bial drugs demonstrated enhanced efficacy against methicillin
resistant S. aureus.62 In that case, tannic acid was able to
prolong and potentiate the bactericidal activity of fusidic acid,
cefotaxime, minocycline and rifampicin, with a similar effect
demonstrated for combinations of quercetin with fusidic acid,
minocycline and rifampicin.
Amongst the vast variety of phytochemicals, phenolics,
terpenoids and other essential oils constituents, alkaloids, lec-
tins and polypeptides, and polyacetylenes are most commonly
associated with antimicrobial activity.32 These phytochemicals
play other roles in plant physiological processes, e.g. avonoids
are the key pigments for plants that reproduce via biotic polli-
nation; avonoids are also involved in UV ltration and
symbiotic nitrogen xation; and as chemical messengers,
physiological regulators, and cell cycle inhibitors. The use of
these antimicrobial agents has been limited to traditional and
alternative medical domains, yet to be recognised by the
mainstream medical community as therapeutic agents. As
mentioned above, one of the main reasons lies in the relatively
weak and/or narrow spectrum of antimicrobial activity, and
potentially high toxicity associated with the administration of
sufficiently high antimicrobial doses. Indeed, the MICs typically
reported for plant-derived antimicrobials are in the range of 100
to 1000 mg ml1, orders of magnitude weaker than MICs of 0.01
to 10 mg ml1 of antimicrobials synthesised by bacteria and
fungi.64 It has been suggested that along with these antimicro-
bials, plants may produce a range of other chemicals, e.g.
inhibitors of bacterial multidrug resistance pumps, which
enhance permeation of the antimicrobials into the bacterial
cells. Furthermore, there is a distinct lack of systematic
description regarding the structure–property of antibacterial
phytochemicals, potentially limiting their mainstream
adoption.
Essential oils are abundant in nature, and most commonly
associated with the distinctive avours and aromas of many
plants.65 Commonly used herbs and spices such as garlic, black
cumin, cloves, cinnamon, thyme, bay leaves, mustard, and
rosemary have essential oils with demonstrated antimicrobial
properties.66 Garlic-derived allicin was found to exhibitRSC Adv., 2015, 5, 48739–48759 | 48745
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View Article Onlineantibacterial activity against a wide range of Gram-negative and
Gram-positive bacteria, including multidrug-resistant enter-
otoxicogenic strains of Escherichia coli; antifungal activity,
particularly against Candida albicans; antiparasitic activity,
including some major human intestinal protozoan parasites
such as Entamoeba histolytica and Giardia lamblia; and antiviral
activity.67 The crude methanolic extracts of such spices and
herbs as cumin (Cuminum cyminum), fennel seed (Nigella sat-
iva), anise (Pimpinella anisum), ajowan (Trachyspermum copti-
cum), and ginger (Zingiber officinale) were demonstrated to be
effective against Gram-positive Bacillus amyloliquefaciens and S.
aureus and Gram-negative E. coli and Pseudomonas aeruginosa
bacteria.68 Importantly, the extracts demonstrated similar or
higher broad-spectrum antimicrobial activity as compared with
ampicillin, erythromycin, and tetracycline.
Extracts of Nigella sativa were also effective against patho-
genic yeast, C. albicans, and its diethyl ether extract was revealed
to be similar in antibacterial activity to that of streptomycin and
gentamicin. Traditionally used to treat urinary tract infections,
a combination of garlic and black cumin has been reported as
being more effective than Cefalexin, Cotrimoxazole, and Nali-
dixic acid in the treatment of this infectious disease.66 Given the
multicomponent nature of the extracts, which included carbo-
hydrates, inulin, alkaloids, glycosides, avonoids, terpenoids,
tannins, reducing sugars, soluble phenols, and saponin glyco-
sides, it is difficult to attribute the observed antimicrobial
activity to a particular constituent (Table 1).68
The antibacterial and antifungal potency of caraway (Carum
carvi) oils are attributed to carvone, limonene and linalool,
while antimicrobial activity of cumin is associated with the
presence of limonene, eugenol, pinene and minor constituents,
and the effect is likely to be synergistic.73 Cumin essential oil
was found to the activity of the ciprooxacin against biolm-
forming Klebsiella pneumoniae strains, although the oil on its
own was not able to induce plasmid DNA degradation.74 C.
cyminum oil was also effective against Vibrio spp. strains.75
Essential oil from rosemary (Rosmarinus officinalis) was shown
to be effective against E. coli, S. aureus and L. monocytogenes,
although it was found less potent in comparison with Cu.
Cyminum essential oil.76 Peppermint (Mentha piperita) oil was
demonstrated to be more effective than chlorhexidine in pre-
venting biolm formation by Streptococcus mutans and Strepto-
coccus pyogenes, with potential to be used in therapies against
supragingival dental plaque.77
A survey of 35 different Indian spices showed clove,
cinnamon, bishop's weed, chili, horse radish, cumin, tamarind,
black cumin, pomegranate seeds, nutmeg, garlic, onion, tejpat,
celery, have potent antimicrobial activities against the test
organisms Bacillus subtilis, E. coli and Saccharomyces cer-
evisiae.78 Oils of chilli, cinnamon, cloves, ginger, nutmeg,
oregano, rosemary, sage, thyme demonstrated a range of
activities against psychrotrophic Aeromonas hydrophila, Listeria
monocytogenes and Yersinia enterocolitica, from complete inhi-
bition of growth in the case of cinnamon and cloves against A.
hydrophila to no inhibition.79 The antimicrobial potency was
also found to vary with the oil acquisition method, e.g. oil
harvesting at different stages of plant development. Thyme48746 | RSC Adv., 2015, 5, 48739–48759(Thymus vulgaris) oil harvested at four ontogenetic stages had a
signicant bacteriostatic activity against nine strains of Gram-
negative bacteria and six strains of Gram-positive bacteria.
However, the activity was the highest for the oil harvested from
the plants in full ower.80
Although oils and their individual components, such as
terpenoids, carvacrol, thymol, have been recognised as poten-
tial antimicrobial agents, yet their exact mechanism of actions
has not been fully elucidated. In part, this may be due to the
numerous components that can potentially complement and/or
enable the efficacy of the other component. For instance, Bro-
phy et al. analysed over 800 samples of M. alternifolia essential
oil by gas chromatography and mass spectrometry and found
approximately 100 components in oil ofM. alternifolia as well as
signicant batch to batch variation.81 The comparison may be
complicated further by different methods used to quantify
antibacterial activity (which also oen differ from those used for
evaluation of surface-immobilised antimicrobial agents).82–84
Oil from Australian native plant Melaleuca alternifolia has
been reported to have the broad-spectrum activity against
bacteria, including drug-resistant strains, fungi, viruses, and
protozoa,85–88 but similar to other phytochemicals, in vivo and in
vitro characterisation of tea tree oil thus far remains inade-
quate. Nonetheless, various preparations that include tea tree
oil are readily available commercially in many countries,
including in Australia, Europe, and North America. Tea tree oil
is composed of terpene hydrocarbons based on an isoprene
structure, mainly monoterpenes (C10H16), sesquiterpenes
(C15H24), and their associated alcohols (terpenoids), with the
antimicrobial activity of the oil is attributed mainly to terpinen-
4-ol. The mechanism of action of terpenes is yet to be fully
described but is believed to involve membrane disruption by the
lipophilic compounds.63,89 In the case of tea tree oil, the ability
of tea tree oil to disrupt the permeability barrier of cell
membrane structures and the accompanying loss of chemios-
motic control were identied as the most likely source of its
lethal action against E. coli, S. aureus, and Candida albicans.90
The predisposition to lysis, the loss of 260 nm-absorbing
material, the loss of tolerance to NaCl, and the altered
morphology by S. aureus cells suggest that tea tree oil and its
components compromise the cytoplasmic membrane.91,92
Essential oils and their constituents are believed to interact
with the bacterial membrane, causing disruption through
lipophilic products (Fig. 6). These disruptions then lead to
membrane expansion, increase of membrane uidity and
permeability, disturbance of membrane embedded proteins,
inhibition of respiration, and alteration of ion transport
processes in both Gram-positive and Gram-negative bacteria.32
An analysis of the chemical structure of these herbs and spices
shows that the antimicrobial phytochemicals consist of phenols
and oxygen-substituted phenolic rings,63 with the inhibitory
action associated with the –OH groups in phenolic compounds.
Garlic is different in such that it consists of non-aromatic
sulfur compounds (thiosulnates) that carry the antimicrobial
properties. Diallyl thiosulnate (allicin), the phytochemical
agent found in garlic (Allium sativum) and believed to be
responsible for the antibacterial and antifungal activity ofThis journal is © The Royal Society of Chemistry 2015
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View Article Online
Fig. 6 Proposed mechanism of action and target sites of secondary
plant metabolites on microbial cells. Reproduced with permission
from ref. 93.
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View Article Onlineextracts of this plant is thought to interact with intracellular
thiols and thiol containing enzymes, including alcohol dehy-
drogenase, thioredoxin reductase and RNA polymerase.67 This
can affect essential metabolism of cysteine proteinase activity
involved in the virulence of E. histolytica. The effect of bacte-
riostatic concentrations of allicin (0.2 to 0.5 mM) on the growth
of Salmonella typhimurium was characterised by a delayed and
partial inhibition of DNA and protein syntheses and immediate
and total inhibition of RNA synthesis, suggesting that the latter
is the primary target of allicin.94 Garlic extract has also been
shown to inhibit quorum sensing ability of biolm-residing
Pseudomonas aeruginosa, rendering the treated bacteria
susceptible to the bactericidal activity of tobramycin and poly-
morphonuclear leukocytes.95,964. Nature-inspired catechol
chemistry
In addition to nature-inspired antibiofouling and biocidal
surfaces, e.g. lotus leaf, buttery wing and shark skin-like
biomimetic surfaces, bio-inspired chemistries can inuence
the manner in which biomaterials and biomaterial coatings are
synthesized, functionalized and delivered in vivo.22,25,97,98 There
are several methods of surface functionalisation that are
inspired by the aquatic animals that are highly adept at fouling a
variety of solid surfaces, both natural and man-made, in
aqueous environments. Numerous sedentary marine organisms,
including species of mussels, tubeworms, and barnacles attach
to underwater surfaces by means of protein-rich adhesives.97,99
Adhesive proteins form approximately 70 wt% of the cement
of Belanus crenatus, where the proteinaceous cement is released
from the pores to ll the space between the base of the
attachment disk of the animal and the solid surface to which
the organism is attaching. The cement cures within severalThis journal is © The Royal Society of Chemistry 2015hours, forming a high strength bond with attachment strength
of up to 9.3  105 N m2. Where cement produced by adult and
cyprid acorn barnacles (order Sessilia) solidies into a thin layer
directly between the shell and the surface and is characterised
by either solid or reticulate structure,100 the cement produced by
Dosima fascicularis buoy barnacle is a gas-lled, foam-like
structure.101 Whereas the barnacle uses the cement for attach-
ment to surfaces, the Phragmatopoma californica marine worm
uses its glue to build its mineralized shell from sand grains and
fragments of seashell collected from its environment.102 Setting
within 30 s under, the glue forms a microporous water-lled
foam comprised of 50–80 nm spheres, and characterised by a
sharp gradient in porosity.
Water-resistant, material-independent adhesive abilities of
the mollusc (Mytilus edulis) byssus, a proteinaceous liquid from
the phenol gland in the mussel foot that forms an adhesive
holdfast, have been used to guide the development of substrate-
independent adhesive hydrogels.31 Rapid solidication into a
hardened adhesive and excellent adhesion to a variety of
substrates, including tissues, is attributed to reactivity of cate-
chol side chains on 3,4-dihydroxy-L-phenylalanine (DOPA).103
Readily oxidised, catechol side chains form reactive species that
can undergo Michael-type addition, Schiff base formation with
nucleophiles, and radical coupling with other catechols (Fig. 7).
They can also form coordination bonds with diverse metals and
inorganic surfaces, hydrogen bonds, and p–p aromatic inter-
actions. The mechanism by which 3,4-dihydroxy-L-phenylala-
nine interacts with the wet surface depends on the state of the
molecule.104 An atomic force microscopy (AFM) study of a single
molecule immobilised on the scanning tip demonstrated high
strength yet fully reversible, non-covalent interaction with a wet
metal oxide surface, here titanium dioxide. Once 3,4-dihydroxy-
L-phenylalanine was oxidised, the strength of this reversible
interaction signicantly decreased, although a new, high
strength irreversible covalent bond was formed.4.1 Catechol-based hydrogels
The incorporation of these catechol functionalities into water
soluble hydrogels, such as polyethylene glycol, ensures rapid
curing of these gels. The degradation properties of such adhe-
sive hydrogel can be modied, by incorporating enzyme-
degradable sites. For instance, a hydrogel based on poly-
ethylene glycol functionalised by DOPA-mimetic catechol via
biodegradable linker, e.g. an Ala–Ala dipeptide substrate of
elastase, can be degraded by neutrophil elastase, the latter
being a serine protease secreted by activated neutrophils as the
result of their recruitment to a wound or site of local inam-
mation.108 The microstructure, composition and mechanical
properties of the hydrogel can also be tuned by controlling the
input catechol, linker, and polymer backbone.
The hydrogel can be loaded with antibacterial agents for
sustained release. For example, the use of silver nitrate to
oxidize catechol-functionalised polyethylene glycol resulted in
covalent cross-linking of the hydrogel and concomitant reduc-
tion of Ag(I).31 The resultant bulk hydrogels demonstrated
inhibition of Staphylococcus epidermidis and PseudomonasRSC Adv., 2015, 5, 48739–48759 | 48749
Fig. 7 Catechols as versatile platforms in polymer chemistry. (A) A
photograph of a mussel attached to the shell of another mussel. (B)
Schematic representation of the adhesive plaque and byssal thread. (C)
Chemical structure of the DOPA side chain found in mussel adhesive
proteins.105 (D) Illustration of the proposed binding mechanism of
DOPA to two types of surfaces, TiO2 and mica. DOPA and
DOPAquinone, to a lesser extent, can form bidentate binuclear
complexes with the TiO2 surface, whereas the interactions with mica
are much less specific and may result from the hydrogen bonding of
the phenolic OH groups to the oxygen atoms of the cleaved mica
surface. DOPAquinone has no H to donate.106 (E) Possible reaction
pathways of oxidized catechols with amines, thiols or imidazoles
where R0 stands for a polymeric or peptidic backbone.107 Reproduced
with permission from ref. 105–107.
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View Article Onlineaeruginosa due to sustained release of silver, with minimal
detriment to mammalian (3T3 broblast) cell viability.31 When
used as a spin-cast 25 nm-thick coating over titanium dioxide
substrate, the hydrogel resisted fouling by both bacterial and
eukaryotic cells. Due to relatively low content of silver in the thin
lm hydrogel, the non-fouling by mammalian cells was attrib-
uted to the antifouling nature of the polyethylene glycol polymer,
rather than cytotoxicity of released silver. However, the ndings48750 | RSC Adv., 2015, 5, 48739–48759that the toxic effect of silver ions and silver nanoparticles occurs
in a similar concentration range for Escherichia coli, Staphylo-
coccus aureus, human mesenchymal stem cells, and peripheral
blood mononuclear cells challenges this conclusion.109,1104.2 Catechol adhesive layer
Dopamine has been demonstrated to possess the full adhesive
properties of mussel adhesion protein, and can be used as a
thin highly adherent coating on a range of biomaterial surfaces,
organic and inorganic alike. Such dopamine-based surface
coatings are resistant to hydrolysis and provide chemical acti-
vation on material surfaces for selective coupling of molecules
and layers.111 The coating is deposited as poly(dihydroxyindole),
but undergoes oxidation to polyorthoquinoneindole upon
exposure to basic (pH 8.5) conditions.112 To this layer, biomol-
ecules containing amine moieties can be covalently bonded via
Schiff base type interactions, or Michael type reactions in the
case of those molecules with amine and thiol functionalities.
In addition to monolayers via self-assembly of long-chain
molecular building blocks, secondary reactions on the
dopamine-modied surfaces can be used for deposition of
metal lms by electroless metallization, and bioinert and
bioactive surfaces via graing of macromolecules.113 Silver
nanoparticles were immobilised onto ferromagnetic Fe2O3
nanoparticles/brous bacterial cellulose nanocomposite by
soaking dopamine-treated composite in silver nitrate solu-
tion.114 Dopamine coating was also shown to be a suitable
platform for fabrication of polymer brushes via atom transfer
radical polymerization.
The utility of barnacle cement for surface functionalisation
has been demonstrated on stainless steel, where the adhesive
was used as a surface anchor for coupling of functional polymer
brushes via “click” reactions in both “graing-to” and “graing-
from” processes.115 A surface rich in thiol, alkyne, and azide
groups was obtained by rst depositing a thin layer of the
cement onto the metallic surface. The reactive amine and/or
hydroxyl groups on the surface100 were then allowed to react
with ethylene sulde, propargyl carbonylimidazole, and azi-
doethyl carbonylimidazole, respectively, to introduce the
desired functionality. Using these molecular anchors, a variety
of stable functional polymer brush coatings were developed,
including antifouling zwitterionic 2-methacryloyloxyethyl
phosphorylcholine surfaces (via thiol photo polymerisation);
protein-resistant hydrophilic poly(poly(ethylene glycol) methyl
ether methacrylate) and protein-adsorbing hydrophobic
poly(2,3,4,5,6-pentauorostyrene) brushes (via azide–alkyne
click reaction); antifouling poly(N-hydroxyethyl acrylamide) and
antimicrobial poly(2-(methacryloyloxy)ethyl trimethylammo-
nium chloride) surfaces (via alkynyl–azide click chemistry).115
Of the developed coatings, the zwitterionic and hydrophilic
surfaces were most effective in reducing bovine serum albumin
adsorption, with the zwitterionic, antifouling, and antimicro-
bial surfaces inhibiting the adhesion of Gram-negative E. coli
and Gram-positive S. epidermidis. Similar to hydrophilic poly(-
ethylene glycol) and oligo(ethylene glycol), the antifouling
properties of zwitterionic and polyampholyte polymer brushesThis journal is © The Royal Society of Chemistry 2015
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View Article Onlinerely on the formation of a strong hydrogen-bonded hydration
layer, which limits protein interactions with the underlying
surface.116 Surfaces rich in alkyl halide functionalities were also
obtained by reacting the amine and hydroxyl moieties of
barnacle cement with 2-bromoisobutyryl bromide.117 The initi-
ator can be used for the surface-initiated atom transfer radical
polymerization of 2-hydroxyethyl methacrylate, the hydroxyl
groups of which can then be converted to carboxyl groups for
coupling of chitosan. Thus functionalised stainless steel
surfaces displayed antifouling property against bovine serum
albumin and antibacterial activity against E. coli.Fig. 8 Examples of plasma-treated surfaces. (A) Petal- and tree-like
graphene networks. (B) Titanium pillars structured in bulk material
using reactive ion etching with fluorine plasma. (C) Collagen-grafted
titanium surface via allylamine-glow discharge treatment and collagen
crosslinking. Reprinted with permission from ref. 133–135.5. Plasma-assisted nanofabrication
Plasma-assisted technologies, especially those based on low-
temperature, non-equilibrium plasmas, have found numerous
applications in medicine, materials science, and biotech-
nology.118,119 The ability to remove biomolecules, such as
proteins, pyrogens or peptides, and bacterial spores from
biomaterial surfaces at high rates and low temperatures make
plasma-assisted treatment an effective and practical tool for
decontamination and sterilization of biomaterials and
medically-relevant devices and surfaces.120–122 The neutral and
reactive species, particularly reactive oxygen species (ROS) and
reactive nitrogen species (RNS), electric elds, charges, and
photons generated in low temperature ionized gas plasmas are
responsible for the well-documented antimicrobial activity of
these plasmas when applied directly to media.123,124 The low
temperature (at or below physiological level) of such plasmas
allow for their application onto living tissues, e.g. a wound,
where they can be used to sterilise, suppress inammation, and
promote healing.125,126
The unique chemistry of these plasmas also enables selective
biomanipulation of the cells, where they can be used to increase
cell proliferation, locally inuence cell adhesion without
causing necrosis or to initiate cell removal via induction of
apoptosis, the result dependent on the dose.127,128 The selectivity
whereby only one type of cells is affected, i.e. cancer cells and
not healthy cells in co-culture, has a clear potential as a safer
means for anti-cancer therapy.129–132
From biomaterials perspective, plasma-assisted techniques
are widely used for lasting, highly controlled modication of a
variety of medically relevant surfaces.136–138 Indeed, over the last
20 years, plasma-enabled nanoscale synthesis and modication
have evolved from a relatively simple tool for materials science
and microelectronics into a highly sophisticated instrument for
development of a wide range of pure and hybrid nanoscale
objects spanning across a vast number of materials systems and
length scales (Fig. 8).139 At the present level of development, low-
temperature plasmas afford chemists andmaterial scientists the
level of condence comparable to, and in many cases superior
to, conventional processing techniques, e.g. based on thermal
chemical vapour deposition (CVD), wet chemistry-based
synthesis and processing, laser-assisted microfabrication etc.139
Importantly, tailored plasmas enable the attainment of certain
objectives conventional fabrication methodologies fail toThis journal is © The Royal Society of Chemistry 2015achieve, such as providing the means for one-step green
synthesis of functional materials from natural precursors.140–1445.1 Types of low-temperature plasma processing
Lower temperature processing suitable for temperature-
sensitive biomaterials and implantable thin lm structures
and for production of polymer lms where the functionality of
the monomer is retained can be attained in low pressure, low
energy plasma systems. In non-equilibrium plasma processing,
the substrate is exposed to a reactive environment of a partially
ionised gas comprising large concentrations of excited atomic,
molecular, ionic, and free-radical species. The nature of the
interactions between the excited species and the solid surface
will determine the type and the degree of the chemical and
physical modication that will take place, from lm deposition,
substitution, cross-linking to ablation. Generally, polymer
deposition occurs when a monomer, either in vapour phase or
at the surface, is fragmented into reactive species that then
recombine and are deposited onto the surface of the substrate.
As mentioned previously, even those monomers that do not
contain functionalities required for conventional polymerisa-
tion, e.g. C]C or ring structures, can be deposited in this way.
When lm deposition is not desired, gases that do not
fragment into polymerisable intermediates upon excitation are
employed. Air, nitrogen, argon, oxygen, nitrous oxide, helium,
tetrauoromethane, water vapour, carbon dioxide, methane,
and ammonia are amongst the most common gases used for
surface modication. Exposure to these plasmas may result in
the chemical functionalisation of the surface, with the degree
and nature of the functionalities being highly dependent on the
chemical composition of the biomaterial and the process gas.
Plasma-assisted surface oxidation, nitration, hydrolysation, or
amination are commonly used to increase the surface energy
and hydrophilicity of the biomaterial. Surface ablation can also
result from such plasma-exposure, whereby lower molecular
weight species, such as volatile oligomers and monomers, areRSC Adv., 2015, 5, 48739–48759 | 48751
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View Article Onlinedesorbed from the surface of the biomaterial. Cross-linking
occurs when radicals from one chain on the surface of the
polymer combine with radicals from another polymer chain to
form a bond, thus changing the mechanical surface properties
of the material. When plasma-generated radicals recombine
with atoms or chemical groups that are different from those
originally present at the surface of the biomaterial, surface
activation takes place. Surface activation can also take place
through opening of dangling bonds on the surface.
The surface functionalities that arise as a result of plasma
deposition or functionalization can serve as a platform for
further surface modication processes, such as the graing of
biomolecules and other functional structures,61,136 and to tune
the properties of the biomaterial for a specic application.145
Surfaces coated with plasma polymers can be used to bind
proteins specically via covalent linkages, e.g. streptavidin
conjugation to aldehyde groups where the binding ability of the
protein is retained, or nonspecically through other irreversible
adsorption mechanisms, e.g. streptavidin binding to ethanol
plasma polymer surfaces where protein denaturation
occurred.146 Chemical gradients with different density of a
specic functionality or with a changing concentration of two
functional groups across the biomaterial surface can be fabri-
cated via plasma polymerisation by using a mask.147 Such
gradients can be highly useful for investigations of microbial
and eukaryotic cell response to variations in surface chemistry,
with each sample serving as a platform for high-throughput
testing of a range of cell–surface interactions.148 Morpholog-
ical gradients can also be obtained with the help of plasma
polymerization, whereby a surface is rst functionalised with a
specic moiety, e.g. amine, and then subjected to controlled
immersion into the solution of nanoparticles.149 The variation
in nanoparticle density gives rise to differences in surface
roughness, the effect of which on cell adhesion andmetabolism
can be investigated independently of surface chemistry with an
addition of thin plasma polymer top layer. Furthermore,
biomolecules (e.g. proteins) that display selective attachment to
given nanoparticles can be immobilised on these surfaces.
These surfaces can then be used to study the effect of biomol-
ecule density on cell–surface interactions.5.2 Controlling plasma-assisted surface modication
The processing conditions, such as power delivered to the
reactor, pressure within the reactor, monomer molecular
weight and ow rate, presence of feed gas, etc. will determine
activation, fragmentation, rearrangement and recombination of
the monomer units in plasma. The key determinant of the
modication outcome is the amount of energy delivered into
the chamber in relation to the building units (from which
polymers and nanostructures are synthesised) or to substrate
material (in the case of etching).
Monomers do not always need to be fragmented; however, in
a plasma environment, there are more options for monomer
fragmentation. When fragmentation takes place, it typically
involves the elimination of hydrogen atoms, and the scission of
C–C bonds. Retention of the original chemical functionality48752 | RSC Adv., 2015, 5, 48739–48759within the resultant polymer deposit is highly dependent on the
degree of monomer fragmentation. The technological challenge
here lies in the ability to retain the desired chemistry and at the
same time attain sound mechanical properties, desired density,
stability, and adhesion to substrate in the material.150,151 To
address this challenge, it is important to understand the
mechanisms implicated in the plasma-assisted deposition of
the polymer onto the surface.
While surface radical–plasma radical interactions were
considered the primary route of polymer deposition for many
years,152 recent ndings have implicated ion adsorption and/or
neutral graing as potential drivers for plasma polymer
formation at the surface.153–156 The mechanism to explain these
phenomena centred on the energies at which depositing species
arrive at the surface of the substrate. Under low pressure, low
power conditions commonly used for fabrication of functional
polymer coatings, neutral species such as radicals and unfrag-
mented precursor molecules reach the surface at nearly
ambient temperature (0.03–0.05 eV). On the other hand, ions
are accelerated to the surface by the difference between the
respective potentials of bulk plasma and the surface and thus
arrive at the surface with much higher energies (15–20 eV).157
The higher energy of ions is sufficient to break chemical bonds
at the biomaterial surface, leading to the formation of surface
radicals. These radicals are then available for neutral graing as
per surface radical–plasma radical model, and can also promote
cross-linking within the plasma polymer.
There is a clear link between the process parameters, the
mechanism of lm growth, and the resultant chemical and phys-
ical properties of the polymer structure.157 The chemical structure
of the organic precursor was found to be critical, in particular, at
low powers. The increased monomer fragmentation at high power
reduces the ability of unsaturated monomers to grow via neutral
graing. For saturated monomers, there is a direct link between
the deposition rate and ion ux to the substrate, whereas for
unsaturated monomers, the neutral ux also plays a role.153 The
material properties of these lms also varied signicantly. Poly-
mers deposited from saturated monomers were characterised by
higher moduli, lower solubility, and lower density compared to
those grown from unsaturated precursors. As the utility of plasma
coatings is reliant on the combination of desirable chemistry and
morphology, as well as good substrate adhesion, controlled
stability and suitable mechanical properties, understanding the
relationship between the process parameters and material prop-
erties is crucial in the design of plasma polymer lm processes to
fully harness the unique plasma-specic chemistries and physical
phenomena of non-equilibrium plasmas (Fig. 9).5.3 Pulsed plasma deposition
Although low-power, low-pressure and low-temperature depo-
sition is more conducive to the fabrication of plasma polymers
with retained functionalities, the degree of fragmentation is still
relatively high. As a result, polymers fabricated using this
method retain only a fraction of the functionality present in the
precursor, and are typically highly cross-linked and amorphous.
Lowering power and temperature may reduce fragmentationThis journal is © The Royal Society of Chemistry 2015
Fig. 9 Processes that may take place during plasma treatment.
Fig. 10 (A) Pulsed plasma deposition allows for fabrication of poly-
mers that consist of more chemically-regular products than those
fabricated by means of continuous wave plasma deposition, where
predominantly random radical recombination occurs.159 (B) Abundant
in functional groups, pulsed plasma treated surfaces can be used for
covalent immobilisation of polymer brushes.160 Reproduced with
permission from ref. 159 and 160.
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View Article Onlineeven further, preserving more of the chemical structure present
in the precursor. Yet, the utility of these coatings in vitro and in
vivo is limited by their poor mechanical and chemical stability,
and oen unsatisfactory attachment to the substrate. These
issues may be circumvented by pulsed plasma deposition,
where two distinct regimes are employed (Fig. 10).
In contrast to continuous wave plasmas, monomer activa-
tion and generation of reactive site on the surface occur only
during on-periods (typically microseconds) whereas polymeri-
sation takes place during off-periods (usually milliseconds) in
the absence of UV-, ion-, or electron-induced damage to the
growing lm.158
The resultant polymer is characterised by high retention of
original chemistries, good stability and covalent attachment of the
grown lm to the substrate at the free radical sites generated
during the on-period. By controlling the input power,161 pulsing
frequency and the duration of the pulse it is possible to tune
chemical functionality, surfacemorphology and density of desired
chemical functionality at the polymer surface.162,163 The process is
highly versatile in terms of resultant surface chemistry, with
pyridine,158 anhydride,164 amine,165 ester,166 hydroxyl,167–169 sulfonic
acid,170 carboxylic acid,171 cyano,172,173 epoxide,174 halide,175
thiol,137,176 and furan177 functionalised surfaces reported.5.4 Plasma-assisted processing of essential oils
The limited understanding of the exact mechanism of anti-
bacterial efficacy of the essential oils and their individual
compounds signicantly limited their potential clinical uses,
especially as part of antimicrobial coatings for medical
implants. Indeed, most in vitro and in vivo studies to date
employed phytochemicals in their liquid or vapour, unbound
form. Tea tree oil delivered into the cavities of prostatic
abscesses in dogs in place of aspirated purulent matter resulted
in the disappearance of the purulent matter in the cavities and a
marked reduction in the volume of the cavities.178
The ability of using these antimicrobials for site-specic
applications, such as in release-based or non-leaching
surfaces remains largely undiscovered. A range of polymer
coatings based on ultra-high molecular weight polyethylene,
very high molecular weight polyethylene and latex compounds
and incorporating a wide range of biocidal phytochemical
agents, alone and in combinations, have been proposed, withThis journal is © The Royal Society of Chemistry 2015primary area of application beingmarine paints and coatings.179
In another patent, anti-fouling coating composition containing
capsaicin were proposed, although these were not designed for
medical implantation applications.180 A polymer system loaded
with a variety of phytochemicals, phytonutrients, and chemical
releasers has also been designed to inhibit the growth of
pathogenic bacteria associated with packaged foodstuff.181
Recently, a number of antibacterial coatings containing curcu-
min have been developed. Sodium carboxymethyl cellulose
silver nanocomposite lms were loaded with curcumin by
diffusion mechanism, with higher encapsulation of the agent
observed in the lms with higher cellulose content.182 Silver
nanoparticles also enhanced the encapsulation of curcumin,
suggesting a degree of interaction between these two antimicro-
bials. The synergistic effect between silver nanoparticles and
curcuminwas also observed in the antimicrobial activity against E.
coli, with the activity being superior to either silver- or curcumin-
only lms. Sustained release and sound antibacterial efficacy was
also observed for silver/curcumin-containing hydrogels based on
poly(acrylamide)/poly(vinyl sulfonic acid sodium salt)183 and those
based on chitosan–poly(vinyl alcohol) lms.184
Although promising, the aforementioned strategies relied on
the use of other polymers or chemical substances to produce aRSC Adv., 2015, 5, 48739–48759 | 48753
Fig. 11 SEM images of attachment and proliferation of Streptococcus
epidermidis (left panel) and Staphylococcus aureus (right panel) after
18 h incubation on surfaces subjected tomonoterpene alcohol plasma
deposition under varied input power conditions: (A and B) 10W; (C and
D) 50W. Scale bar¼ 2 mm; 20 mm (inset).190 (E) Surface area covered by
Escherichia coli biofilm formed on plasma polymerised 1,8-cineole
(ppCo) and hydrophobic (ppOct) and hydrophilic (glass) controls.
Samples were immersed in bacterial culture for 5 days (***p < 0.001,
**p < 0.01, *p < 0.1).191 Reproduced with permission from ref. 190
and 191.
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View Article Onlinecoating. Using non-equilibrium, low-temperature plasma poly-
merisation, Jacob and Bazaka and their colleagues demonstrated
the possibility of producing solid polymer lms exclusively from
essential oils, including M. alternifolia and Lavandula angustifo-
lia essential oils and their individual constituents.141,143 Fabri-
cated over a wide range of processing parameters, these lms
varied in terms of chemical composition, surface morphology,
stability and mechanical properties, while displaying uniform
coverage and sound adhesion to a variety of substrates,
including metals, ceramics, and polymers.185,186 Polymers fabri-
cated from M. alternifolia oil and its major antimicrobial
component terpinen-4-ol was demonstrated to be cytocompat-
ible with a number of host cells. In combination with biological
activity, their attractive optoelectronics properties make
terpinen-4-ol lms as potential candidates for inclusion in
implantable electronics, where they can be used as both the
device components and protective encapsulating layers.144,187–189
Films fabricated at conditions that favoured preservation of
original functionalities of the monomer via limited48754 | RSC Adv., 2015, 5, 48739–48759fragmentation and incorporation of unfragmented species into
the polymer matrix were able to retard attachment and coloni-
sation by such bacteria as P. aeruginosa, S. aureus, S. epidermidis,
and E. coli.141,142,192 Fig. 11 shows the attachment preferences of
two pathogens, S. aureus and S. epidermidis to polymers fabri-
cated at three different input power levels.190 Surfaces rich in
oxygen containing functional groups, particularly –OH, were
characterised by higher antifouling and biocidal activity
compared to more hydrocarbon dense coatings. In addition to
availability of specic functionalities at the surface, it has been
speculated that unfragmented monomer trapped within the
polymer during deposition may be eluting over time, thus
contributing to inhibition of biolm formation at the polymer
surface. It is believed that just as unmodied monomer, the
eluted agent would interfere with the bacterial wall, leading to
the suppression of cell biosynthesis, disruption of transport
across the cell wall, loss of membrane integrity, and an increase
in passive ux of protons across the membrane. However, the
levels of the leached agent are sufficiently low to insure good
cytocompatibility with mammalian cell lines.
Furthermore, the antimicrobial effect of these coatings is
maintained over time under dry and wet conditions. Plasma
polymer thin lms fabricated from 1,8-cineole were able to
successfully retard bacterial colonisation and biolm formation by
Escherichia coli for over 5 days, whereas plasma polymers of 1,7-
octadiene, although hydrophobic and biolm-retarding at early
stages of bacterial exposure failed to maintain this activity. These
results suggest that surface-immobilised and/or leachable constit-
uents of cineol are primarily responsible for the observed activity.
The above examples relied on low-energy processing condi-
tions to preserve the original chemistry of the lm. However,
increasing the processing energy can also produce useful
structures fabricated from essential oils. Indeed, non-
equilibrium and kinetics-driven phenomena of cold low-
temperature plasma are oen used for a simple, catalyst-free
and highly-efficient production of self-organized nano-solids,
e.g. graphenes nanowalls.193,194 While many other techniques
exist for the fabrication of functional graphene sheets, most
require the use of hazardous chemicals or toxic gases, complex,
multistage processing, and are energy-, time-, and resource-
consuming. In addition to being quick and efficient, the
plasma-assisted processes allow for good adhesion to the
substrate, and preservation of original minerals present in the
precursor, resulting in varying chemistries andmorphologies of
the fabricated layers. It is worth noting that although plasma-
assisted fabrication can substantially lower the overall pro-
cessing temperature, the plasma heating effects limit the suit-
ability of the technique for processing of polymers and other
temperature-sensitive biomaterials.140
Graphene-based nanomaterials have been demonstrated to
effectively inhibit the growth of bacteria, while showing
minimal cytotoxicity to mammalian cell lines.197–201 Toxicity of
graphene nanosheets in the form of graphene nanowalls on
stainless steel towards E. coli and P. aeruginosa bacteria was
attributed to the cell membrane damage from direct contact of
the bacteria with the extremely sharp edges of the nanowalls,195
and a combination of membrane and oxidation stress, leadingThis journal is © The Royal Society of Chemistry 2015
Fig. 12 (A) Nanowalls of graphene oxide (GONWs) and reduced gra-
phene (RGNWs) kill Gram-negative and Gram-positive bacteria upon
direct contact, by causing membrane damage and loss of intracellular
material (RNA). Sharper edges and a better charge transfer between
the bacteria and the edge of the reduced nanowalls leads to more
effective killing.195 (C–G) Mechanism of contact killing of graphenes.
Respiratory proteins on the surface of bacteria behave as n-type
semiconductors. The physical contact of bacteria with semimetal
graphene results in Schottky barrier formation and Fermi level align-
ment. Electrons are then effectively transferred from microbial
membranes to graphene acceptors and then to underlying conductor
or semiconductor substrate (C and F). For graphene on insulating
substrate (G), the electrons cannot be transferred to the underlying
insulator, with bacteria cells remaining alive. Reproduced with
permission from ref. 195 and 196.
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View Article Onlineto DNA fragmentation and loss of cell viability.197–199 The
sharper edges and more effective charge transfer between the
bacteria and the nanowalls of reduced graphene oxide were
responsible for its higher microbial toxicity compared to gra-
phene oxide. The signicance of direct interaction between
bacterial membrane and the edge also meant that Gram-
negative E. coli bacteria were more resistant compared to
S. aureus which do not have an outer membrane.
Fig. 12(B) shows the structure of vertically-oriented graphe-
nes prepared from Melaleuca alternifolia essential oil using
plasma chemical vapour deposition. The graphene sheets had
good adhesion to the substrate, low level of defects, and
enhanced surface area with ultra-long edges. From the average
circumference (about 600 nm) of the top edge of a well-like
structure, the total length of the edges/folds in 1 cm2 area of a
sample was estimated to be2.6 km. Furthermore, plasmas can
be used to chemically functionalise graphenes fabricated in this
fashion during or post-synthesis, to thin the edges of graphene
walls even further, or to decorate the surfaces with other
nanostructures, creating more complex topographies.This journal is © The Royal Society of Chemistry 20156. Conclusions
The continuous serious clinical complications related to multi-
drug resistant pathogens have motivated researchers to explore
alternative antibacterial agents whose mode of action differs
sufficiently from the existing synthetic antibiotics, minimising
the opportunity for bacteria to acquire resistance. Nature
provides us with an abundant source of plant and animal-
derived chemicals that have been specically evolved by these
organisms to ward off microbial invasion. Great physico-
chemical diversity of these agents also brings about a signi-
cant challenge – only a very small fraction of the available
agents have been identied. Their mechanism is even more
elusive, as host organisms typically employ several defensive
strategies that may complement, enhance and enable the
activities of other contributors.
Lack of consistency with regard to in vitro and in vivo testing
reported in the literature oen makes it difficult to compare
these chemicals against each other and, importantly, against
established antimicrobials. Limited understanding of the
structure–property relationship of these antimicrobials makes
it difficult to devise strategies for their controlled spatio-
temporal delivery, thus hindering their potential application
as coatings for implantable devices. In order to be used in
practical applications, in addition to sound antimicrobial
performance, the antimicrobials should be compatible with the
processing, integration, implantation, and operation condi-
tions. In turn, the processing environment should be exible to
accommodate a variety of surface modications, allow for
control of both physical and chemical surface characteristics,
and should not compromise the biological performance of the
bulk material with regard to its intended application nor
diminish the efficacy of the antimicrobial agent. Plasma-
enabled surface processing is a family of technologies that
have the potential to amply address these requirements. Future
research is ought to be directed towards development of
plasma-enabled and other surface fabrication and modication
methodologies with the capacity to independently control
chemical, physical and biological properties of the material.Acknowledgements
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